A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
Treatment of Cushing's Disease With R-roscovitine
Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)
Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer
† Study has passed its completion date and status has not been verified in more than two years.